Term
4 Mechanisms to control BP |
|
Definition
Renal
Renin-Angiotensin-Aldosterone
SNS
Vascular Tone |
|
|
Term
|
Definition
Most Na and H20 reabsorption |
|
|
Term
|
Definition
Impermeable to H20->hyperosmolar zone |
|
|
Term
|
Definition
Reabsorbs a little Na, basically impermeable to H20 |
|
|
Term
|
Definition
Water is reabsorbed and urine is concentrated
Where aldosterone has its effects to reabsorb Na and H20 to increase BP, while excreting K |
|
|
Term
|
Definition
Released from JG cells
Increases Na and water reabsorption, therefore increasing BP
Converts angiotensinogen to angiotensin I
What controls renin release? activation of kidney beta1 receptors, macula densa cells sense too little Na and increase renin secretion, intrarenal baroreceptor senses low BP |
|
|
Term
|
Definition
Angiotensin I to Angiotensin II
Degrades bradykinin (a vasodilator) |
|
|
Term
|
Definition
Binds to AT1 receptors in vascular smooth muscle to raise BP
Increases aldosterone secretion to increase BP
Also increases BP by:
Increases SNS activity
Increases Na reabsorption in PCT
Immediate: Direct vasoconstriction and SNS stimulation
Renal effects: Delayed
SNS and renin-angiotensin-aldosterone system stimulate each other and are mutually reinforcing
Sustained high levels can cause cardiac remodeling and hypertrophy |
|
|
Term
|
Definition
CNS baroreceptor can activate if BP drops
Clonidine and methyldopa are used to reduce BP by targeting vasomotor center to decrease SNS outflow
Alpha or Beta blockers modulate SNS activity |
|
|
Term
|
Definition
Ca chanels can lead to a wave of depolarization in surrounding cells->targeting them ends spread of depolorization
K channels are normally closed to prevent K from leaving cell and allow depolorization, but if drugs allow it to exit it causes membrane hyperpolorization and relaxation |
|
|